chr4-92304774-A-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001510.4(GRID2):c.88+30A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00155 in 1,471,020 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0077 ( 17 hom., cov: 32)
Exomes 𝑓: 0.00084 ( 15 hom. )
Consequence
GRID2
NM_001510.4 intron
NM_001510.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.00
Genes affected
GRID2 (HGNC:4576): (glutamate ionotropic receptor delta type subunit 2) The protein encoded by this gene is a member of the family of ionotropic glutamate receptors which are the predominant excitatory neurotransmitter receptors in the mammalian brain. The encoded protein is a multi-pass membrane protein that is expressed selectively in cerebellar Purkinje cells. A point mutation in the mouse ortholog, associated with the phenotype named 'lurcher', in the heterozygous state leads to ataxia resulting from selective, cell-autonomous apoptosis of cerebellar Purkinje cells during postnatal development. Mice homozygous for this mutation die shortly after birth from massive loss of mid- and hindbrain neurons during late embryogenesis. This protein also plays a role in synapse organization between parallel fibers and Purkinje cells. Alternate splicing results in multiple transcript variants encoding distinct isoforms. Mutations in this gene cause cerebellar ataxia in humans. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 4-92304774-A-T is Benign according to our data. Variant chr4-92304774-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 1722914.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00774 (1177/152156) while in subpopulation AFR AF = 0.0269 (1118/41524). AF 95% confidence interval is 0.0256. There are 17 homozygotes in GnomAd4. There are 571 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRID2 | ENST00000282020.9 | c.88+30A>T | intron_variant | Intron 1 of 15 | 1 | NM_001510.4 | ENSP00000282020.4 | |||
GRID2 | ENST00000510992.5 | c.88+30A>T | intron_variant | Intron 1 of 14 | 1 | ENSP00000421257.1 | ||||
GRID2 | ENST00000505687.5 | n.260+30A>T | intron_variant | Intron 1 of 5 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00772 AC: 1174AN: 152038Hom.: 17 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1174
AN:
152038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00210 AC: 522AN: 248750 AF XY: 0.00151 show subpopulations
GnomAD2 exomes
AF:
AC:
522
AN:
248750
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000836 AC: 1103AN: 1318864Hom.: 15 Cov.: 21 AF XY: 0.000711 AC XY: 472AN XY: 664158 show subpopulations
GnomAD4 exome
AF:
AC:
1103
AN:
1318864
Hom.:
Cov.:
21
AF XY:
AC XY:
472
AN XY:
664158
Gnomad4 AFR exome
AF:
AC:
895
AN:
30836
Gnomad4 AMR exome
AF:
AC:
74
AN:
44506
Gnomad4 ASJ exome
AF:
AC:
0
AN:
25298
Gnomad4 EAS exome
AF:
AC:
0
AN:
39060
Gnomad4 SAS exome
AF:
AC:
4
AN:
83274
Gnomad4 FIN exome
AF:
AC:
0
AN:
53352
Gnomad4 NFE exome
AF:
AC:
38
AN:
981332
Gnomad4 Remaining exome
AF:
AC:
89
AN:
55702
Heterozygous variant carriers
0
53
107
160
214
267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00774 AC: 1177AN: 152156Hom.: 17 Cov.: 32 AF XY: 0.00768 AC XY: 571AN XY: 74392 show subpopulations
GnomAD4 genome
AF:
AC:
1177
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
571
AN XY:
74392
Gnomad4 AFR
AF:
AC:
0.0269242
AN:
0.0269242
Gnomad4 AMR
AF:
AC:
0.00255202
AN:
0.00255202
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000735294
AN:
0.0000735294
Gnomad4 OTH
AF:
AC:
0.00616698
AN:
0.00616698
Heterozygous variant carriers
0
58
115
173
230
288
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Dec 07, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
See Variant Classification Assertion Criteria. -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at